Studi Clinici
Il paziente di Epatocentro, con cui la Fondazione lavora a stretto contatto, ha la possibilità di accedere a metodi di diagnosi e opportunità terapeutiche all’avanguardia e, nell’ambito di uno studio clinico, a trattamenti innovativi 1 - 2 anni prima della loro messa in commercio.
PATOLOGIA
TIPOLOGIA DI STUDIO
STATO DELLO STUDIO
STATO DI ARRUOLAMENTO
A Study to Evaluate the Safety and Effect of the Experimental Drugs ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Subjects With Chronic Hepatitis C (PEARL-II)
PATOLOGIA: Hepatitis C Virus HCV
A Study to Evaluate Chronic Hepatitis C Infection
PATOLOGIA: Hepatitis C Virus HCV
Effectiveness Of Daclatasvir-Based Regimens In Patients With Chronic Hepatitis C Infection In Europe: Experience From Named Patient Program And From Early Post-Marketing Authorization Period
PATOLOGIA: Hepatitis C Virus HCV
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Subjects With Genotype 1 Infection
PATOLOGIA: Hepatitis C Virus HCV
A Study Comparing Efficacy and Safety of ABT-493/ABT-530 to Sofosbuvir Dosed With Daclatasvir in Adults With HCV Genotype 3 Infection (ENDURANCE-3)
PATOLOGIA: Hepatitis C Virus HCV
Assessment of liver stiffness in HCV infected patients undergoing antiviral treatment with new DAA
PATOLOGIA: Hepatitis C Virus HCV
The health burden of Primary Biliary Cirrhosis in Switzerland
PATOLOGIA: Colangite Biliare Primitiva PBC
Seroprevalence of liver autoantibodies in patients with acute hepatitis E infection
PATOLOGIA: Hepatitis E Virus HEV
A Phase IV Trial of Paritaprevir/Ritonavir, Ombitasvir, Dasabuvir for Chronic Hepatitis C Genotype 1 Virus Infection (D3FEAT)
PATOLOGIA: Hepatitis C Virus HCV
Retrospective analysis of the outcomes of HCV infected individuals in the hospital setting in Switzerland
PATOLOGIA: Hepatitis C Virus HCV
Liver autoantibodies in patients with chronic hepatitis C infection treated by direct acting antiviral agents
PATOLOGIA: Hepatitis C Virus HCV
Quality of Life Measurement in Treatment Naïve Patients With HCV Genotype 1 Suffering From Fatigue and Receiving Ombitasvir, Paritaprevir, and Ritonavir and Dasabuvir (Viekirax®/Exviera®) (HEMATITE)
PATOLOGIA: Hepatitis C Virus HCV
Study of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C Genotypes 1 to 6
PATOLOGIA: Hepatitis C Virus HCV
Phase 2b Study in NASH to Assess IVA337 (NATIVE)
PATOLOGIA: Statoepatite non alcolica NASH
A Two-year Study to Evaluate the Efficacy and Safety of Deferasirox Film-coated Tablet Versus Phlebotomy in Patients With Hereditary Hemochromatosis
PATOLOGIA: Emocromatosi ereditaria
Safety, Tolerability, and Efficacy of a Combination Treatment of Tropifexor (LJN452) and Cenicriviroc (CVC) in Adult Patients With Nonalcoholic Steatohepatitis (NASH) and Liver Fibrosis (TANDEM)
PATOLOGIA: Statoepatite non alcolica NASH
Safety, Tolerability, Pharmacokinetics and Efficacy of LMB763 in Patients With NASH
PATOLOGIA: Statoepatite non alcolica NASH
ADCC Mediated B-Cell dEpletion and BAFF-R Blockade (AMBER)
PATOLOGIA: Epatite autoimmune
Randomised Study of Interferon-free Treatment for Recently Acquired Hepatitis C in PWID and People With HIV Coinfection (REACT)
PATOLOGIA: Hepatitis C Virus HCV
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (REGENERATE)
PATOLOGIA: Non-alcoholic Statohepatitis NASH
Swiss Liver Venous Thrombosis Study
PATOLOGIA: Trombosi venosa portale
Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis (STELLAR 3)
PATOLOGIA: Statoepatite non alcolica NASH
Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) (STELLAR 4)
PATOLOGIA: Statoepatite non alcolica NASH
Reducing the Burden of Influenza after Solid-Organ Transplantation: the STOP-FLU trial [Swiss Trial in solid Organ transplantation on Prevention of inFLUenza]
PATOLOGIA: Trapianto